Trade Summary

2 days ago, Jacobson Mark L., serving as COO at Axsome Therapeutics, Inc. (AXSM), sold 4,750 shares at $227.95 per share, for a total transaction value of $1,082,771.00.

This sale represents a 100.00% decrease in Jacobson Mark L.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 4, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 5, 2026, 1 day after the trade was made.

Axsome Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.